1,2,4,5-Tetraoxane Conjugates as a Novel Ferrous Iron-Activatable Platform for Targeted Tumor Drug Delivery
Elevated intracellular labile ferrous iron is a hallmark of many cancers and can activate endoperoxide-containing molecules through Fenton chemistry. We developed a ferrous iron-activatable drug conjugate (FeADC) platform based on a 1,2,4,5-tetraoxane scaffold for tumor-selective drug delivery. Doxorubicin-loaded tetraoxane conjugates release their payload in the presence of Fe(II) via tandem endoperoxide reduction and retro-Michael elimination. These FeADCs exhibited potent antiproliferative activity across cancer cell lines with dysregulated iron metabolism while displaying markedly improved selectivity over doxorubicin in nontumorigenic cells. Fluorescence microscopy confirmed the efficient intracellular release of doxorubicin in HCT116 colorectal cancer cells. Moreover, in a colorectal cancer xenograft model, the tetraoxane conjugate achieved tumor growth inhibition comparable to that of doxorubicin administered at an equivalent dose. Collectively, these findings establish the 1,2,4,5-tetraoxane scaffold as a promising ferrous iron-responsive platform for tumor-activated prodrugs, enabling targeted drug release and potentially improving the therapeutic index of anticancer agents.
Authors
- Maria Manuela Gaspar (ORCID: https://orcid.org/0000-0001-6814-7226)
- Andreia Bento‐Silva (ORCID: https://orcid.org/0000-0002-3047-0586)
- Cláudia Mourato (ORCID: https://orcid.org/0000-0002-7805-4346)
- Vanda Marques (ORCID: https://orcid.org/0000-0003-3515-0781)
- Adam R. Renslo (ORCID: https://orcid.org/0000-0002-1240-2846)
- Rui Moreira (ORCID: https://orcid.org/0000-0003-0727-9852)
- Francisca Lopes (ORCID: https://orcid.org/0000-0002-5350-147X)
- Catarina I. G. Pinto (ORCID: https://orcid.org/0000-0002-4195-5810)
- Ricardo Lopes (ORCID: https://orcid.org/0000-0002-0364-5053)
- Diogo Silva (ORCID: https://orcid.org/0000-0001-7576-5719)
- Cecília M. P. Rodrigues (ORCID: https://orcid.org/0000-0002-4829-754X)
Institutions
- University of Lisbon (PT)
- University of California, San Francisco (US)
Publication Details
- Journal
- ACS Pharmacology & Translational Science
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1021/acsptsci.6c00516
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- “la Caixa” Foundation
- Fundação para a Ciência e a Tecnologia
- European Regional Development Fund
- NHLBI Division of Intramural Research